Tracking Kidney Disease in Ireland
CKD is a common condition that is associated with a significant economic burden across the world1. The prevalence of the disease is rising, owing in part to an increase in the median age of populations worldwide, and the growing number of individuals with diabetes mellitus (DM) or hypertension. When CKD progresses, patients may experience complications such as anaemia, cardiovascular disease (CVD), peripheral arterial disease, pruritus, and increased risk of infection. Both disease progression and its associated complications require medical treatment, which further impacts patients’ quality of life (QoL) and contributes to the humanistic and economic burden of CKD.
Moreover, progression to end-stage renal disease (ESRD) has a significant effect on patients’ daily lives and is often associated with considerable costs due to the common requirement for renal replacement therapy (RRT) via dialysis or kidney transplantation. Therefore, slowing the rate of progression of CKD to advanced stages,in particular to ESRD, is an important medical objective.
The aim of the NKDSS is accurately monitor and improve the delivery, quality and outcomes of care provided to patients with chronic kidney disease (CKD) or at risk of kidney disease in the Irish health system
The Health Service Executive (HSE) provides all of Ireland’s public health services in hospitals and communities across the country.
The National Renal Office (NRO) provides Governance, Integration and Leadership in developing a National Framework for delivering Renal Services in Ireland. It is embedded within the Clinical Strategies and Programmes Division and links with the Chief Executive Officer of the Hospital Groups as well as the Integrated Services Directorates
The Central Statistics Office (CSO) is Ireland’s national statistical office and it’s purpose is to impartially collect, analyse and make available statistics about Ireland’s people, society and economy.
The overall goal of the National Kidney Disease Surveillance System (NKDSS) and Quality Assurance (QA) Programme is to improve the delivery, quality and outcomes of care provided to patients with chronic kidney disease (CKD) or at risk of kidney disease in the Irish health system.
It will allow physicians and health care providers within the Health Services Executive (HSE) to quantify the burden of kidney disease in the population, assess the quality of delivered care and measure outcomes that are benchmarked against national and international standards.
The programme will analyse routinely collected clinical information on patients who are treated in primary care and secondary care settings
There is a lack of information on the epidemiology of CKD in Ireland.
The mission of the NKDSS is :
The NKDSS uses a novel combination of deterministic and probabilistic matching to link regional and national datasets in the absence of a unique identifier and generates pseudonymised datasets to address these deficits in knowledge.
This programmes novel approach provides a cost-effective solution for describing the natural history of kidney disease and its clinical consequences in the Irish health system.
It will provide a better understanding of this complex illness and it will help inform national policy on prevention efforts and management practices.
We conduct and support clinical, epidemiological and translational research while fostering research training and mentoring opportunities to create new knowledge and to improve health of patients with CKD.
Tell Us Your Story